This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Concept
|
Antibodies, Bacterial
|
|
Concept
|
Antibodies, Viral
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Hepatitis B Antibodies
|
|
Concept
|
Hepatitis Antibodies
|
|
Concept
|
Hepatitis A Antibodies
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Academic Article
|
Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
|
|
Academic Article
|
Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls.
|
|
Academic Article
|
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis.
|
|
Academic Article
|
Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction.
|
|
Academic Article
|
Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study.
|
|
Academic Article
|
Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment.
|
|
Academic Article
|
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.
|
|
Academic Article
|
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
|
|
Academic Article
|
Monoclonal antibodies to proteins from cocksfoot grass (Dactylis glomerata) pollen: isolation and N-terminal sequence of a major allergen.
|
|
Academic Article
|
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.
|
|
Academic Article
|
Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.
|
|
Academic Article
|
The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.
|
|
Academic Article
|
Immunogenicity of pneumococcal revaccination in patients with chronic disease.
|
|
Academic Article
|
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.
|
|
Academic Article
|
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
|
|
Academic Article
|
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
|
|
Academic Article
|
Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
|
|
Academic Article
|
Clinical trials.
|
|
Academic Article
|
Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
|
|
Academic Article
|
Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
|
|
Academic Article
|
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
|
|
Academic Article
|
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
|
|
Academic Article
|
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
|